Evidence for benefit of antiretroviral resistance testing is sparse and limited to small short-term improvements of virologic response, mostly with GART and less with vPART. Current guidelines widely recommending the use of antiretroviral resistance testing in clinical practice are not commensurate with the available evidence.
John D. Baxter, Douglas L. Mayers, Deborah Wentworth, James D. Neaton, Marie L. Hoover, Mark A. Winters, Sharon Mannheimer, Melanie Thompson, Donald I. Abrams, Barbara Brizz, John P A Ioannidis, Thomas C. Merigan
Kristien Van Vaerenbergh, Thomas Harrer, Jean‐Claude Schmit, An Carbonez, Elodie Fontaine, Michael Kurowski, Mathias Grünke, Peter Löw, Astrid Rascu, Bárbara Schmidt, Matthias Schmitt, Inge Thoelen, H Walter, Kristel Van Laethem, Marc Van Ranst, Jan Desmyter, De Clercq Erik, Anne‐Mieke Vandamme
Steven G. Deeks, Terri Wrin, Teri Liegler, Rebecca Hoh, Matthew S. Hayden, Jason D. Barbour, Nicholas S. Hellmann, Christos J. Petropoulos, Joseph M. McCune, Marc Hellerstein, Robert M. Grant
Discussion(0)
No comments yet. Be the first to comment.